Joaquin Urdinez is the QC Manager at CUTISS AG, a Swiss Life Science company, spin-off of the University of Zurich. He holds a master in Pharmaceutical Biotechnology from St. John’s University, and a PhD in Sciences from UZH/ETHZ. In between his studies, he worked as a GMP Purification Analyst in mabXience and as a Process Developer for the NYC-based startup Symbiotic Health. His doctorate studies where focused on discovery and validation of biomarkers for rare bone cancer types. In 2019 he joined CUTISS AG as a Senior Researcher, focused on method development relevant for cell therapies (denovoSkin™ and pigmentation program).